Delivery Order SPE2DB22D3004-SPE2DB24FRD71

Award Date 7/24/24
Potential Completion Date 7/25/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,187.50 firm-fixed-price contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a medication. The order has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. The company also holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a medication, with a firm fixed price of $1,848.78 and a completion date of May 15, 2025. The contract is not set aside and was awarded on May 14, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a $18,739.89 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of Rifampin 300 mg capsules, with a period of performance through July 26, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of essential...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $74,441.56, is for the delivery of 4567394898 RIFAMPIN 300 MG CAPSULE 30S to be completed by February 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,968.32 firm fixed price delivery order is for the supply of RIFAMPIN 300 MG CAPSULE 60S, a critical pharmaceutical product. The contract has a completion date of November 15, 2024 and was awarded on November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,046.98 firm fixed price contract is for the delivery of 60 capsules of 300 mg rifampin, a prescription medication. The order has an ultimate completion date of September 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,466.34, is for the delivery of 4567604349 RIFAMPIN 300 MG CAPSULE 30S. The contract is a Firm Fixed Price Delivery Order, with a period of performance ending on March 19, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RIFAMPIN 300 MG CAPSULE UD 100S. The contract has a firm fixed price, a ceiling value of $11,383.20, and an ultimate completion date of June 24, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,258.33, is for the delivery of Rifampin 300 mg capsules. The contract is a Firm Fixed Price type with an ultimate completion date of January 13, 2023. The award was made on January 12, 2023, and there was no set-aside designation for the contract. AmerisourceBergen holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,883.16 firm fixed-price contract is for the supply of 60 capsules of the drug Rifampin 300 mg. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FRD71
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $3,426.18 firm fixed-price contract is for the supply of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product. The order has an ultimate completion date of July 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies to provide a wide range of medical commodities, including prescription drugs and medical supplies, in support of military treatment programs and federal healthcare needs. This specific award does not have a set-aside designation.

Generated 10/23/24, 9:41 AM